Webinars and Virtual Workshops
Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder
FDA is hosting a virtual public meeting on Patient-Focused Drug Development for Stimulant Use Disorder. This meeting will provide FDA the opportunity to obtain input from individuals who are struggling or have struggled with the use of cocaine, crystal meth, methamphetamine, or misuse of prescription stimulants such as Adderall or Ritalin. Family members, advocates, caregivers and other stakeholders are encouraged to participate and share their views on the condition.
October 6, 2020; 12:30 PM - 5:00 PM ET
Please register here.
FDA is hosting a virtual public meeting on Patient-Focused Drug Development for Stimulant Use Disorder. This meeting will provide FDA the opportunity to obtain input from individuals who are struggling or have struggled with the use of cocaine, crystal meth, methamphetamine, or misuse of prescription stimulants such as Adderall or Ritalin. Family members, advocates, caregivers and other stakeholders are encouraged to participate and share their views on the condition.
October 6, 2020; 12:30 PM - 5:00 PM ET
Please register here.
.png)
No hay comentarios:
Publicar un comentario